Literature DB >> 2352645

Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal.

A S Kimes1, J A Bell, E D London.   

Abstract

The effect of two doses of clonidine on regional cerebral metabolic rates for glucose were measured during morphine withdrawal in rats. In the first study, 0 or 200 micrograms/kg clonidine was administered to rats subjected to naloxone-precipitated morphine withdrawal (naloxone, 0.5 mg/kg, s.c.), and to non-dependent control rats. In a second study of similar design, 0 or 20 micrograms/kg clonidine were administered. Withdrawal signs in rats subjected to naloxone-precipitated morphine withdrawal and receiving 0, 20 or 200 micrograms/kg clonidine were also assessed. Naloxone-precipitated morphine withdrawal stimulated regional cerebral metabolic rates for glucose (59 of 83 regions in study no. 1; 73 of 83 regions in study no. 2). At 200 micrograms/kg, clonidine attenuated this effect (33 of 59 regions). Although 200 micrograms/kg clonidine directly suppressed regional cerebral metabolic rates for glucose in many regions (significant main effect of clonidine), it attenuated the naloxone-precipitated morphine withdrawal effect specifically in the lateral septal nucleus, medial habenula, subiculum and gracile nucleus (significant interactions between clonidine and morphine withdrawal). The 20 micrograms/kg dose of clonidine had no statistically significant effect. In behavioral experiments, both doses of clonidine diminished withdrawal in that there was no diarrhea, fewer wet-dog shakes and less abnormal posturing. However, locomotion, grooming and jumping were increased by clonidine. Most of these effects were statistically significant only with the 200 micrograms/kg dose. The results of these studies show that clonidine reduces morphine withdrawal-induced increases in regional cerebral metabolic rates for glucose in many brain regions, irrespective of the distribution of alpha 2-adrenoceptors. Although clonidine has been thought to ameliorate morphine withdrawal by actions primarily at the locus coeruleus and central amygdala, it may play a major role in other regions as well.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2352645     DOI: 10.1016/0306-4522(90)90170-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase.

Authors:  A S Kimes; D B Vaupel; E D London
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal.

Authors:  D B Vaupel; A S Kimes; E D London
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

3.  Endogenous cholinergic neurotransmission contributes to behavioral sensitization to morphine.

Authors:  Dusica Bajic; Mariano Soiza-Reilly; Allegra L Spalding; Charles B Berde; Kathryn G Commons
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

Review 4.  The role of the habenula in drug addiction.

Authors:  Kenia M Velasquez; David L Molfese; Ramiro Salas
Journal:  Front Hum Neurosci       Date:  2014-03-28       Impact factor: 3.169

5.  Agmatine modulates spontaneous activity in neurons of the rat medial habenular complex-a relevant mechanism in the pathophysiology and treatment of depression?

Authors:  Torsten Weiss; René Bernard; Hans-Gert Bernstein; Rüdiger W Veh; Gregor Laube
Journal:  Transl Psychiatry       Date:  2018-09-24       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.